Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
acetylcholinesterase | 2 | 0 | 0 | 2 |
thioredoxin reductase | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 3 | 0 | 0 | 3 |
AR protein | 2 | 0 | 0 | 2 |
signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
putative alpha-glucosidase | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Matrix protein 2 | 0 | 1 | 1 | 2 |
Matrix protein 2 | 0 | 1 | 2 | 3 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Spike glycoprotein | 2 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
geminin | 3 | 0 | 0 | 3 |
Luciferase | 2 | 0 | 0 | 2 |
interleukin 8 | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
progesterone receptor | 2 | 0 | 0 | 2 |
retinoic acid nuclear receptor alpha variant 1 | 2 | 0 | 0 | 2 |
retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 3 | 0 | 0 | 3 |
peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
Histone H2A.x | 1 | 0 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Chain A, Dutpase | 0 | 0 | 1 | 1 |
Chain A, Dutpase | 0 | 0 | 1 | 1 |
Chain B, Dutpase | 0 | 0 | 1 | 1 |
Chain A, Dutpase | 0 | 0 | 1 | 1 |
Chain B, Dutpase | 0 | 0 | 1 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
TDP1 protein | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
Vpr | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
Interferon beta | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 2 |
30S ribosomal protein S7 | 0 | 1 | 0 | 2 |
50S ribosomal protein L15 | 0 | 1 | 0 | 2 |
50S ribosomal protein L10 | 0 | 1 | 0 | 2 |
50S ribosomal protein L11 | 0 | 1 | 0 | 2 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 2 |
50S ribosomal protein L19 | 0 | 1 | 0 | 2 |
50S ribosomal protein L1 | 0 | 1 | 0 | 2 |
50S ribosomal protein L20 | 0 | 1 | 0 | 2 |
50S ribosomal protein L27 | 0 | 1 | 0 | 2 |
50S ribosomal protein L28 | 0 | 1 | 0 | 2 |
50S ribosomal protein L29 | 0 | 1 | 0 | 2 |
50S ribosomal protein L31 | 0 | 1 | 0 | 2 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 2 |
50S ribosomal protein L32 | 0 | 1 | 0 | 2 |
50S ribosomal protein L33 | 0 | 1 | 0 | 2 |
50S ribosomal protein L34 | 0 | 1 | 0 | 2 |
50S ribosomal protein L35 | 0 | 1 | 0 | 2 |
50S ribosomal protein L36 | 0 | 1 | 0 | 2 |
30S ribosomal protein S10 | 0 | 1 | 0 | 2 |
30S ribosomal protein S11 | 0 | 1 | 0 | 2 |
30S ribosomal protein S12 | 0 | 1 | 0 | 2 |
30S ribosomal protein S13 | 0 | 1 | 0 | 2 |
30S ribosomal protein S16 | 0 | 1 | 0 | 2 |
30S ribosomal protein S18 | 0 | 1 | 0 | 2 |
30S ribosomal protein S19 | 0 | 1 | 0 | 2 |
30S ribosomal protein S20 | 0 | 1 | 0 | 2 |
30S ribosomal protein S2 | 0 | 1 | 0 | 2 |
30S ribosomal protein S3 | 0 | 1 | 0 | 2 |
30S ribosomal protein S4 | 0 | 1 | 0 | 2 |
30S ribosomal protein S5 | 0 | 1 | 0 | 2 |
30S ribosomal protein S8 | 0 | 1 | 0 | 2 |
30S ribosomal protein S9 | 0 | 1 | 0 | 2 |
50S ribosomal protein L13 | 0 | 1 | 0 | 2 |
50S ribosomal protein L14 | 0 | 1 | 0 | 2 |
50S ribosomal protein L16 | 0 | 1 | 0 | 2 |
50S ribosomal protein L23 | 0 | 1 | 0 | 2 |
30S ribosomal protein S15 | 0 | 1 | 0 | 2 |
50S ribosomal protein L17 | 0 | 1 | 0 | 2 |
50S ribosomal protein L21 | 0 | 1 | 0 | 2 |
50S ribosomal protein L30 | 0 | 1 | 0 | 2 |
50S ribosomal protein L6 | 0 | 1 | 0 | 2 |
30S ribosomal protein S14 | 0 | 1 | 0 | 2 |
30S ribosomal protein S17 | 0 | 1 | 0 | 2 |
30S ribosomal protein S1 | 0 | 1 | 0 | 2 |
50S ribosomal protein L18 | 0 | 1 | 0 | 2 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Puromycin-sensitive aminopeptidase | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 2 |
50S ribosomal protein L3 | 0 | 1 | 0 | 2 |
50S ribosomal protein L24 | 0 | 1 | 0 | 2 |
50S ribosomal protein L4 | 0 | 1 | 0 | 2 |
50S ribosomal protein L22 | 0 | 1 | 0 | 2 |
50S ribosomal protein L5 | 0 | 1 | 0 | 2 |
30S ribosomal protein S21 | 0 | 1 | 0 | 2 |
50S ribosomal protein L25 | 0 | 1 | 0 | 2 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
Chain A, MALTOPORIN | 0 | 0 | 1 | 1 |
Chain B, MALTOPORIN | 0 | 0 | 1 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 1 | 2 |
Carbonic anhydrase 9 | 0 | 1 | 1 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |